Cerulean Pharma Inc., a clinical stage company developing nanoparticle-drug conjugates (NDCs), today announced completion of enrollment of a randomized Phase 2 trial of its lead NDC, CRLX101, in combination with Avastin®, in third- and fourth-line relapsed renal cell carcinoma (RCC). The trial has enrolled all 110 patients and the company expects to announce top-line data in the first half of 2016.
The recently opened National Graphene Institute (NGI) has been crowned Major Building Project of the Year at the annual British Construction Industry Awards.
Report Details: The graphene market is very new and in the embryonic stage with only a few products being commercialised yet. However, we forecast an increasing number of graphene companies will drive investment over the coming years resulting in wider adoption of graphene across a range of industries.
At any given time, almost half the population of the developing world suffers from waterborne diseases. About four billion cases of diarrhea disease occur each year, resulting in about one million deaths. An assessment by the United Nations reports that four out of 10 people in Africa and Asia do not have access to clean water. As a matter of fact, a report published in the medical journal The Lancet concluded that unsafe drinking water takes on a greater human toll than terrorism and war combined. Hepatitis A, typhoid and cholera are all caused by bacteria and are the most common diarrheal diseases. Other illnesses like dysentery are caused by parasite that live in water contaminated by animal or people feces.
PV Nano Cell, an innovative producer of single-crystal nano-metric conductive digital inks, today announced that it has signed a Memorandum of Understanding (MOU) with a leading manufacturer of printed circuit boards (PCBs) pursuant to which PV Nano Cell will provide, and the manufacturer will exclusively use, PV Nano Cell's Sicrys™ portfolio of conductive inks for the mass production of PCBs.
Technavio has published a new report on the global textile machinery market, which is expected to grow at a CAGR of over 13% from 2015-2019.
An enzyme called telomerase plays a significant role in aging and most cancers, but until recently many aspects of the enzyme's structure could not be clearly seen.
The MinION, a handheld DNA-sequencing device developed by Oxford Nanopore, has been tested and evaluated by an independent, international consortium coordinated by EMBL’s European Bioinformatics Institute (EMBL-EBI). The innovative device opens up new possibilities for using sequencing technology in the field, for example in tracking disease outbreaks, testing packaged food or the trafficking of protected species.
A smaller system makes on-the-spot detection easier and cheaper
Paper sensors that can be analyzed using an Android program on a smartphone could be used to detect pesticides rapidly and cheaply, according to a new study published in Biosensors and Bioelectronics.
Research and Markets has announced the addition of the "Nanopatterning - Global Strategic Business Report" report to their offering.
Perovskite solar cells are the rising star in photovoltaics. They absorb light across almost all visible wavelengths, they have exceptional power conversion efficiencies exceeding 20% in the lab, and they are relatively easy to fabricate. So, why are perovskite solar cells yet to be found on the top of our roofs? One problem is their overall cost, and another is that cheaper perovskite solar cells have a short lifespan.
Localized conductive regions, that measure as small as 4 nm across, have been patterned into graphene oxide. The environmentally friendly method uses no harmful solvents and occurs at a low temperature.
By Jake Wilkinson
15 Oct 2015
Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company focused on identifying and developing safe and effective therapeutics for the treatment of serious and life-threatening infections, today announced that it will be presenting at the 14th Annual BIO Investor Forum being held October 20-21, 2015, at the Parc 55 in San Francisco, California.
Nano One Materials Corp. ("Nano One" or the "Company") (TSX-V:NNO) wishes to announce that the U.S. Patent and Trademark Office has recently issued to Nano One U.S. Patent No. 9,159,999 entitled "Complexometric Precursor Formulation Methodology For Industrial Production Of Fine And Ultrafine Powders And Nanopowders Of Lithium Metal Oxides For Battery Applications".
Totally internal confined whispering-gallery modes can have high Q factors in wavelength scale optical microresonators, such as microspheres and two-dimensional microdisk resonators. Square optical resonators can also support high Q whispering-gallery modes, suitable to realize unidirectional microlasers.